Doctor profile · Federal record
Dr. IRENE ZIDE, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · LAWRENCE, NY
- NPI 1932209590
- Accepts Medicare
- MIPS 85.0 / 100 · 2023
- 47 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
290 CENTRAL AVE STE 202
LAWRENCE, NY 115598507
(516) 371-0517
fax (516) 371-0519
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #151719
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932209590. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,279
Distinct HCPCS
10
Medicare allowed
$298,100
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 5,040 | 47 | $23 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 882 | 338 | $3 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 850 | 396 | $149 | |
83036 |
Hemoglobin a1c level | 365 | 222 | $9 | |
36415 |
Insertion of needle into vein for collection of blood sample | 323 | 184 | $8 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 323 | 133 | $39 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 232 | 80 | $62 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 148 | 123 | $106 | |
96372 |
Injection of drug or substance under skin or into muscle | 104 | 50 | $17 | |
95249 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 12 | 12 | $76 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 514. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$165
Transactions
2
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| BETA BIONICS, INC. | 1 | $108.08 | |
| CeQur Corporation | 1 | $56.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,111
Patients
825
Total drug cost
$2,007,388
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Synthroid (Levothyroxine Sodium) | Brand | 430 | 112 | $35,562 |
| Levothyroxine Sodium | Generic | 349 | 103 | $6,200 |
| Ozempic (Semaglutide) | Brand | 337 | 72 | $456,745 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 334 | 115 | $7,216 |
| Trulicity (Dulaglutide) | Brand | 304 | 50 | $362,339 |
| Metformin Hcl | Generic | 259 | 89 | $4,390 |
| Jardiance (Empagliflozin) | Brand | 232 | 61 | $272,296 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 165 | 38 | $178,921 |
| Mounjaro (Tirzepatide) | Brand | 161 | 31 | $211,766 |
| Tradjenta (Linagliptin) | Brand | 121 | 32 | $130,973 |